[4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane
C26H34ClN5O — CID 145325570
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane
[4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane (PubChem CID 145325570) has the molecular formula C26H34ClN5O and a molecular weight of 468.05 g/mol. Its IUPAC name is [4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane.
Molecular Properties
| Compound Name | [4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane |
|---|---|
| PubChem CID | 145325570 |
| Molecular Formula | C26H34ClN5O |
| Molecular Weight | 468.05 g/mol |
| Exact Mass | 467.25 |
| IUPAC Name | [4-[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl]-piperazin-1-ylmethanone;propane |
| SMILES | CCC.O=C(N1CCNCC1)N1CCC(c2cn(-c3ccc(Cl)cc3)c3cnccc23)CC1 |
| InChI | InChI=1S/C23H26ClN5O.C3H8/c24-18-1-3-19(4-2-18)29-16-21(20-5-8-26-15-22(20)29)17-6-11-27(12-7-17)23(30)28-13-9-25-10-14-28;1-3-2/h1-5,8,15-17,25H,6-7,9-14H2;3H2,1-2H3 |
| InChIKey | DIEPPVXAZIAWES-UHFFFAOYSA-N |
| XLogP | 5.30 |
| TPSA | 53.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.05 |
| LogP ≤ 5 | 5.30 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145325570 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.